Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Por Patnaik, M M, Tefferi, A
Publicado no Blood Cancer J (2016)

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

Por Goyal, G, Bartley, A C, Patnaik, M M, Litzow, M R, Al-Kali, A, Go, R S
Publicado no Blood Cancer J (2017)

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

Por Kenderian, S S, Al-Kali, A, Gangat, N, Letendre, L, Hogan, W J, Litzow, M R, Patnaik, M M
Publicado em 2013

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

Por Patnaik, M M, Lasho, T L, Vijayvargiya, P, Finke, C M, Hanson, C A, Ketterling, R P, Gangat, N, Tefferi, A
Publicado no Blood Cancer J (2016)

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Por Tefferi, A, Al-Kali, A, Begna, K H, Patnaik, M M, Lasho, T L, Rizo, A, Wan, Y, Hanson, C A
Publicado no Blood Cancer J (2016)

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

Por Patnaik, M M, Zahid, M F, Lasho, T L, Finke, C, Ketterling, R L, Gangat, N, Robertson, K D, Hanson, C A, Tefferi, A
Publicado no Blood Cancer J (2016)

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

Por Laborde, R R, Patnaik, M M, Lasho, T L, Finke, C M, Hanson, C A, Knudson, R A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado em 2013

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

Por Gangat, N, Patnaik, M M, Begna, K, Al-Kali, A, Litzow, M R, Ketterling, R P, Hanson, C A, Pardanani, A D, Tefferi, A
Publicado no Blood Cancer J (2016)

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis

Por Patnaik, M M, Timm, M M, Vallapureddy, R, Lasho, T L, Ketterling, R P, Gangat, N, Shi, M, Tefferi, A, Solary, E, Reichard, K K, Jevremovic, D
Publicado no Blood Cancer J (2017)

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

Por Saeed, L, Patnaik, M M, Begna, K H, Al-Kali, A, Litzow, M R, Hanson, C A, Ketterling, R P, Porrata, L F, Pardanani, A, Gangat, N, Tefferi, A
Publicado no Blood Cancer J (2017)

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26

Por Perez Botero, J, Oliveira, J L, Chen, D, Reichard, K K, Viswanatha, D S, Nguyen, P L, Pruthi, R K, Majerus, J, Gada, P, Gangat, N, Tefferi, A, Patnaik, M M
Publicado no Blood Cancer J (2015)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Por Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Publicado no Blood Cancer J (2015)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Por Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Publicado no Blood Cancer J (2015)

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations...

Por Patnaik, M M, Lasho, T L, Finke, C M, Gangat, N, Caramazza, D, Holtan, S G, Pardanani, A, Knudson, R A, Ketterling, R P, Chen, D, Hoyer, J D, Hanson, C A, Tefferi, A
Publicado em 2010

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

Por Padron, E, Garcia-Manero, G, Patnaik, M M, Itzykson, R, Lasho, T, Nazha, A, Rampal, R K, Sanchez, M E, Jabbour, E, Al Ali, N H, Thompson, Z, Colla, S, Fenaux, P, Kantarjian, H M, Killick, S, Sekeres, M A, List, A F, Onida, F, Komrokji, R S, Tefferi, A, Solary, E
Publicado no Blood Cancer J (2015)